Palantir Technologies Inc. (PLTR) PT Raised to $60 at Jefferies

Jefferies analyst Brent Thill raised the price target on Palantir Technologies Inc. (NASDAQ: PLTR) to $60.00 (from $28.00) while maintaining a Underperform rating.

The analyst comments: "PLTR delivered an exceptional 4Q with a record rev beat, growth acceleration across most top-line metrics and a rule of 81 (36% y/y rev growth, 45% op margin). Fundamentals have been strong and we are constructive on the accelerating US momentum, but CY25 rev guide implies 31% growth vs 29% in CY24, and PLTR would need to accel growth to 50% for 4 years and trade at 18x CY28E rev just to hold its stock price. Maintain Underperform, PT to $60 (30x CY26E rev)."

You May Also Be Interested In

• Incyte (INCY) PT Raised to $105 at Truist Securities
• Truist Securities Reiterates Buy Rating on Kymera Therapeutics (KYMR) Following Sector Deal
• Taysha Gene Therapies (TSHA) PT Raised to $10 at BofA Securities